Tags

Type your tag names separated by a space and hit enter

Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
Br J Pharmacol. 2010 Jul; 160(5):1243-51.BJ

Abstract

BACKGROUND AND PURPOSE

Our recent experiments demonstrated that the Sphingosine-1-phosphate (S1P) receptor agonist FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol hydrochloride) improves recovery of function after myocardial ischaemia-reperfusion ex vivo. Therefore, we tested the hypothesis that pharmacological post-conditioning with FTY720 reduces infarct size after myocardial ischaemia-reperfusion in vivo.

EXPERIMENTAL APPROACH

Myocardial ischaemia was induced in Wistar rats by ligation of the left coronary artery for 45 min. FTY720 (0.5 mg kg(-1)) was applied i.p. either once, before reperfusion, or twice, 24 h before myocardial ischaemia and before reperfusion. After 24 h reperfusion, we determined infarct size by triphenyltetrazolium chloride staining and granulocyte infiltration by immunohistochemistry. Tumour necrosis factor-alpha (TNF)-alpha concentration was determined by elisa. S1P receptor expression was studied by Western blot. Calcium transients were evaluated in Indo-1-loaded cardiomyocytes.

KEY RESULTS

In both groups, FTY720 significantly reduced lymphocyte count in peripheral blood. FTY720 treatment attenuated granulocyte infiltration and TNF-alpha protein expression in reperfused myocardium. However, both treatment regimens were not able to reduce infarct size. FTY720 increased mortality due to induction of fatal ventricular tachyarrhythmias when administered once before reperfusion, but protected against reperfusion arrhythmias when given 24 h prior to ischaemia. Pretreatment selectively down-regulated S1P(1) receptor expression within the myocardium. S1P receptor agonists did not induce calcium deregulation in cardiomyocytes.

CONCLUSIONS AND IMPLICATIONS

FTY720 applied during reperfusion did not reduce infarct size but increased mortality during myocardial ischaemia-reperfusion due to induction of arrhythmias. Pretreatment with FTY720 before ischaemia abrogated the deleterious pro-arrhythmic effects without reducing infarct size.

Authors+Show Affiliations

Department of Internal Medicine I, University Hospital Wuerzburg, Würzburg, Germany. hofmann_u2@medizin.uni-wuerzburg.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20590616

Citation

Hofmann, U, et al. "Pharmacological Pre- and Post-conditioning With the Sphingosine-1-phosphate Receptor Modulator FTY720 After Myocardial Ischaemia-reperfusion." British Journal of Pharmacology, vol. 160, no. 5, 2010, pp. 1243-51.
Hofmann U, Hu K, Walter F, et al. Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion. Br J Pharmacol. 2010;160(5):1243-51.
Hofmann, U., Hu, K., Walter, F., Burkard, N., Ertl, G., Bauersachs, J., Ritter, O., Frantz, S., & Bonz, A. (2010). Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion. British Journal of Pharmacology, 160(5), 1243-51. https://doi.org/10.1111/j.1476-5381.2010.00767.x
Hofmann U, et al. Pharmacological Pre- and Post-conditioning With the Sphingosine-1-phosphate Receptor Modulator FTY720 After Myocardial Ischaemia-reperfusion. Br J Pharmacol. 2010;160(5):1243-51. PubMed PMID: 20590616.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion. AU - Hofmann,U, AU - Hu,K, AU - Walter,F, AU - Burkard,N, AU - Ertl,G, AU - Bauersachs,J, AU - Ritter,O, AU - Frantz,S, AU - Bonz,A, PY - 2010/7/2/entrez PY - 2010/7/2/pubmed PY - 2010/10/12/medline SP - 1243 EP - 51 JF - British journal of pharmacology JO - Br. J. Pharmacol. VL - 160 IS - 5 N2 - BACKGROUND AND PURPOSE: Our recent experiments demonstrated that the Sphingosine-1-phosphate (S1P) receptor agonist FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol hydrochloride) improves recovery of function after myocardial ischaemia-reperfusion ex vivo. Therefore, we tested the hypothesis that pharmacological post-conditioning with FTY720 reduces infarct size after myocardial ischaemia-reperfusion in vivo. EXPERIMENTAL APPROACH: Myocardial ischaemia was induced in Wistar rats by ligation of the left coronary artery for 45 min. FTY720 (0.5 mg kg(-1)) was applied i.p. either once, before reperfusion, or twice, 24 h before myocardial ischaemia and before reperfusion. After 24 h reperfusion, we determined infarct size by triphenyltetrazolium chloride staining and granulocyte infiltration by immunohistochemistry. Tumour necrosis factor-alpha (TNF)-alpha concentration was determined by elisa. S1P receptor expression was studied by Western blot. Calcium transients were evaluated in Indo-1-loaded cardiomyocytes. KEY RESULTS: In both groups, FTY720 significantly reduced lymphocyte count in peripheral blood. FTY720 treatment attenuated granulocyte infiltration and TNF-alpha protein expression in reperfused myocardium. However, both treatment regimens were not able to reduce infarct size. FTY720 increased mortality due to induction of fatal ventricular tachyarrhythmias when administered once before reperfusion, but protected against reperfusion arrhythmias when given 24 h prior to ischaemia. Pretreatment selectively down-regulated S1P(1) receptor expression within the myocardium. S1P receptor agonists did not induce calcium deregulation in cardiomyocytes. CONCLUSIONS AND IMPLICATIONS: FTY720 applied during reperfusion did not reduce infarct size but increased mortality during myocardial ischaemia-reperfusion due to induction of arrhythmias. Pretreatment with FTY720 before ischaemia abrogated the deleterious pro-arrhythmic effects without reducing infarct size. SN - 1476-5381 UR - https://www.unboundmedicine.com/medline/citation/20590616/Pharmacological_pre__and_post_conditioning_with_the_sphingosine_1_phosphate_receptor_modulator_FTY720_after_myocardial_ischaemia_reperfusion_ L2 - https://doi.org/10.1111/j.1476-5381.2010.00767.x DB - PRIME DP - Unbound Medicine ER -